3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
5
Genitourinary
4
Sarcoma
3
Gastrointestinal
3
Dermatologic
2
CNS
2
Thoracic
1
Other solid neoplasm
1
NET
1
Lymphoid
1
Head & Neck
1
Endocrine
1
Breast
1
Conditions
Neuroendocrine Tumors
145
Gastro-enteropancreatic neuroendocrine tumor
29
Carcinoma, Neuroendocrine
18
Neoplasms
15
Breast Neoplasms
13
Adenoma, Islet Cell
13
Carcinoma, Hepatocellular
12
Prostatic Neoplasms
11
Carcinoid Tumor
11
Stomach Neoplasms
10
Pheochromocytoma
10
Pancreatic Neoplasms
10
Colorectal Neoplasms
10
Sarcoma
9
Paraganglioma
9
Thyroid Neoplasms
8
Neoplasm Metastasis
8
Lung Neoplasms
8
Cholangiocarcinoma
8
Small Cell Lung Carcinoma
7
Ovarian Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Anus Neoplasms
7
Rectal Neoplasms
6
Mesothelioma
6
Colonic Neoplasms
6
Carcinoma
6
Brain Neoplasms
6
Uterine Cervical Neoplasms
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma, Clear Cell
×
NET
×
1 year
×
Clear all
NCT05500391
2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2
Recruiting
88 enrolled